InvestorsHub Logo

Shavasana

10/21/14 11:23 AM

#194683 RE: lorekarf #194682

Given that scenario, I would think many long-term shareholders would like to see the pps trickle down even further in order to load up for the eventual FDA approval?

pphmtoolong

10/21/14 11:24 AM

#194684 RE: lorekarf #194682

I'm not sure about Bavi NSCLC FDA approval before the next ASM. However, we may have data from the trial making it clear that such approval will happen. Good enough to get a buyout we can live with.

GLTA, Paul

md1225

10/21/14 4:57 PM

#194710 RE: lorekarf #194682

PCYC was worth 4B two years prior to submitting their BLA.

PPHM will reset when none of us expect it.

Possibly after an amazing trifecta of data in November, breast, lung and liver.

That should take us to 500M MC then watch the big money role in.

PCYC announced J&J partnership within four weeks of their phase II data points.

Trade the news carefully.